These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3488665)

  • 1. Histologic analysis of tissue response to bucrylate-pantopaque mixture.
    Cromwell LD; Freeny PC; Kerber CW; Kunz LL; Harris AB; Shaw CM
    AJR Am J Roentgenol; 1986 Sep; 147(3):627-31. PubMed ID: 3488665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term pathological follow-up of cerebral arteriovenous malformations treated by embolization with bucrylate.
    Vinters HV; Lundie MJ; Kaufmann JC
    N Engl J Med; 1986 Feb; 314(8):477-83. PubMed ID: 3511383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of cyanoacrylate for therapeutic embolization: preliminary experience.
    Cromwell LD; Kerber CW
    AJR Am J Roentgenol; 1979 May; 132(5):799-801. PubMed ID: 107749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological studies of human arteriovenous malformations. Effects of isobutyl 2-cyanoacrylate embolization.
    Klara PM; George ED; McDonnell DE; Pevsner PH
    J Neurosurg; 1985 Sep; 63(3):421-5. PubMed ID: 4020470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of arteriovenous malformations embolized with isobutyl-2-cyanoacrylate (bucrylate). Report of two cases.
    Vinters HV; Debrun G; Kaufmann JC; Drake CG
    J Neurosurg; 1981 Nov; 55(5):819-25. PubMed ID: 7310505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with bucrylate (isobutyl-2-cyanoacrylate) embolization of cerebral arteriovenous malformations during surgery.
    Whittle IR; Johnston IH; Besser M; Lamond TS; de Silva M
    Surg Neurol; 1983 May; 19(5):442-9. PubMed ID: 6845158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term radiographic-pathologic follow-up of patients treated with visceral transcatheter occlusion using isobutyl 2-cyanoacrylate (Bucrylate).
    Freeny PC; Mennemeyer R; Kidd CR; Bush WH
    Radiology; 1979 Jul; 132(1):51-60. PubMed ID: 377379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative embolisation of cerebral arteriovenous malformations with isobutyl-2-cyanoacrylate (bucrylate).
    de Lange JJ; Baerts WD; Pearce C
    Acta Anaesthesiol Belg; 1982; 33(3):211-4. PubMed ID: 6815977
    [No Abstract]   [Full Text] [Related]  

  • 9. A catheter system for the safe and efficient delivery of tissue glues (bucrylate) for visceral embolization.
    Khangure MS; Ap Simon HT; Chakera TM; Hartley DE
    Br J Radiol; 1981 Aug; 54(644):671-3. PubMed ID: 7260525
    [No Abstract]   [Full Text] [Related]  

  • 10. Embolization of cerebral arteriovenous malformations with bucrylate. Experience in a first series of 29 patients.
    Berthelsen B; Löfgren J; Svendsen P
    Acta Radiol; 1990 Jan; 31(1):13-21. PubMed ID: 2340219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term pathological findings of cerebral arteriovenous malformation after embolization].
    Zhou D
    Zhonghua Wai Ke Za Zhi; 1991 Jun; 29(6):377-8, 398. PubMed ID: 1935436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue reactions induced by different embolising agents in cerebral arteriovenous malformations: a histopathological follow-up.
    Mazal PR; Stichenwirth M; Gruber A; Sulzbacher I; Hainfellner JA
    Pathology; 2006 Feb; 38(1):28-32. PubMed ID: 16484004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular use of isobutyl 2-cyanoacrylate: Part 1 Treatment of intracranial arteriovenous malformations.
    Samson D; Ditmore QM; Beyer CW
    Neurosurgery; 1981 Jan; 8(1):43-51. PubMed ID: 7207772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isobutyl-2-cyanoacrylate pulmonary emboli associated with occlusive embolotherapy of cerebral arteriovenous malformations.
    Coard K; Silver MD; Perkins G; Fox AJ; Vinuela EV
    Histopathology; 1984 Nov; 8(6):917-26. PubMed ID: 6526389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cerebral arteriovenous malformations: combined neurosurgical and neuroradiologic approach.
    Cromwell LD; Harris AB
    AJNR Am J Neuroradiol; 1983; 4(3):366-8. PubMed ID: 6410746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental carotid aneurysms: Part 2. Endovascular treatment with cyanoacrylate.
    Kerber CW; Cromwell LD; Zanetti PH
    Neurosurgery; 1985 Jan; 16(1):13-7. PubMed ID: 3974809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution of isobutyl 2-cyanoacrylate on long-term follow-up.
    Rao VR; Mandalam KR; Gupta AK; Kumar S; Joseph S
    AJNR Am J Neuroradiol; 1989; 10(1):135-41. PubMed ID: 2492713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter occlusive therapy of genitourinary abnormalities using isobutyl 2-cyanoacrylate (Bucrylate).
    Freeny PC; Bush WH; Kidd R
    AJR Am J Roentgenol; 1979 Oct; 133(4):647-56. PubMed ID: 90459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staining procedure to aid in assessment of bucrylate histotoxicity in tissue sections.
    Lundie MJ; Ellyatt D; Kaufmann JC; Vinters HV
    Arch Pathol Lab Med; 1985 Aug; 109(8):779-81. PubMed ID: 2409951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous endovascular embolization of intracerebral arteriovenous malformations. Experience in 72 cases.
    Huang Z; Dai Q; Suo J; Liu F; Wang C; Yin W
    Chin Med J (Engl); 1995 Jun; 108(6):413-9. PubMed ID: 7555249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.